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CELL-CELL INTERACTIONS: CLUES TO 
HEPATOCYTE HETEROGENEITY AND BEYOND? 
Kuo FC, and Darnell JE Jr. Evidence that interaction of 
hepatocytes with the collecting (hepatic) veins triggers 
position-specific transcription of the glutamine syn- 
thetase and ornithine aminotransferase genes in the 
mouse liver. Mol Cell Biol 1991;11:6050-6058. 
ABSTRACT 
We previously demonstrated that glutamine syn- 
thetase (GS) and ornithine aminotransferase (OAT) 
mRNAs are expreased in the mouse liver acinus pref- 
erentially in pericentral hepatocytes, that is, those 
immediately surrounding terminal central veins (A. L. 
Bennett, K. E. Padson, R. E. Miller, and J. E. Darnell, 
Jr., J. Cell Biol. 106:1073-1085, 1987, and F. C. Kuo, W. 
L. Hwa, D. Valle, and J. E. Darnell, Jr., Proc. Natl. Acad. 
Sci. USA, (in prees). We now show that hepatocytes 
surrounding large collecting hepatic veins but not 
portal veins also express these two mRNAs. The peri- 
central hepatocytes are the most distal hepatocytes 
with respect to acinar blood flow, whereas this is not 
necessarily the case for hepatocytes next to the large 
collecting hepatic veins. This result implies that it is 
contact with some hepatic venous element which 
signals positional expression. In an effort to induce 
conditions that change relationships between hepato- 
cytes and blood vessels, regenerating liver ww studied. 
After surgical removal of two-thirds or more of the 
liver, there was no noticeable change in GS or OAT 
expredon in the remaining liver tissue during regen- 
eration. However, treatment with carbon tetra- 
chloride (CCl,), which specifically kills pericentral 
hepatocytes, completely removed GS- and OAT- 
containing cells and promptly halted hepatic tran- 
scription of GS. Repair of CCl, damage is associated 
with invasion of idammatory and scavenging cells, 
which remove dead hepatocytes to allow regrowth. 
Only when hepatocytes resumed contact with peri- 
central veins were the pretreatment levels of OAT and 
GS mRNA and high levels of GS transcription restored. 
COMMENTS 
The liver parenchymal cells apparently represent a 
very flexible cell type. In relation to their position along 
the porto-central axis, these cells show a variable degree 
of heterogeneity with respect to enzyme content and 
activity and thus with respect to function (1). This 
heterogeneity responds in a dynamic fashion to changes 
in the physiological state, and the various signals 
participating in its regulation may involve, among 
others, the blood concentrations of oxygen, substrates 
and hormones as well as nervous input (1). A few 
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remarkable exceptions exist. They are the enzymes 
glutamine synthetase (GS) (2) and ornithine ami- 
notransferase (3), which are localized in about 8% of the 
most distal perivenous hepatocytes surrounding the 
terminal hepatic venules. This particular heterogeneity 
plays an important role in nitrogen detoxification, pH 
regulation and possibly several other functions (4). The 
strict limitation of GS expression to some few hepato- 
cytes in a well-defined topographical localization inde- 
pendent of the physiological state has led to the term 
“positional expression” for this particular phenomenon 
and has prompted investigators to assume that the liver 
parenchyma may be subdivided into different “compart- 
ments” of gene expression (5). However, the subtle 
distinction between the generation of such compart- 
ments and cell differentiation, if any does exist, has still 
to be defined. 
In the article under discussion, Kuo and Darnell 
addressed the question of how the positional expression 
of GS might be explained. The following alternatives 
were considered by these authors: is the positional 
expression of these enzymes the result of the location of 
the respective hepatocytes at the most distal end of the 
perivenous zone (i.e., in the most downstream area of 
the lobulus), or is it the result of their contact with the 
central veins? To approach this question Kuo and 
Darnell used selective zonal damage by CC1, to wipe out 
hepatocytes in zone 3 and especially to destroy the 
hepatocytes in contact with the central veins. During 
regeneration after such a treatment, the reestab- 
lishment of the original pattern of GS distribution has 
been observed with immunologically detectable enzyme 
protein occurring only in hepatocytes, which resume 
contact with the central veins (6). Because the induction 
of the respective messenger RNA (mRNA) precedes 
detectable levels of enzyme protein, Kuo and Darnell 
have now strengthened this argument by using in situ 
hybridization to localize the site of the earliest rise in GS 
and ornithine aminotransferase mRNAs. Their results 
clearly demonstrate that contact between hepatocytes 
and pericentral veins triggers the expression of both 
enzymes. Combining these results, one may conclude 
that no hepatocyte located further apart from these 
efferent vessels ever expresses mRNA and protein of 
these enzymes during the process of regeneration, which 
takes at least 5 to 7 days. 
A second argument for the importance of cell-cell or 
cell-matrix interactions raised by Kuo and Darnell relies 
on the observation that a one-cell-thick margin of 
GS-positive hepatocytes can be found even around large 
collecting veins where the layer of hepatocytes is no 
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longer perforated by sinusoids. In this particular case, 
the adjacent hepatocytes do not per se belong to a 
perivenous zone; rather, they may show varying enzyme 
patterns sometimes resembling those of midzonal or 
even periportal hepatocytes because they may occa- 
sionally be located quite close to a portal field. The fact 
that GS is present within all these cells at  a level 
comparable to that in truly perivenous hepatocytes (i.e., 
those surrounding small terminal hepatic veins) sug- 
gests that the location within the acinus is not a major 
determinant for the expression of this enzyme. 
Moreover, in accordance with their otherwise periportal 
phenotype, some of the GS-positive hepatocytes in this 
location may survive even extended exposure to CCl,, 
thus contributing to the residual number of these cells 
found under such conditions (6). 
This argument can even be stressed by looking more 
carefully at the structure of the liver. The hepatocytes 
surrounding the large hepatic veins form some kind of 
a limiting plate that is continuous with the subcapsular 
limiting plate (7). GS, however, is found only in 
hepatocytes around the veins and not in the hepato- 
cytes underneath the capsule, indicating that it must 
be the interaction with the endothelial cells of the 
hepatic veins or with their basement membrane that 
contributes to the acquisition of the GS-positive phe- 
notype. However, no simple explanation exists for the 
fact that the GS-positive area around small branches 
of the central vein is relatively broad (up to three cells 
thick), whereas a one-cell layer is always seen around 
the large vessels, as has been determined directly using 
image analysis (8). 
Although the in uiuo study by Kuo and Darnell 
removes the last doubts of the original hypothesis that 
the heterogeneous distribution of GS may depend on 
cell-cell or cell-matrix-interactions (2), it still leaves us 
with the question of what mechanisms might be in- 
volved. 
In general, such interactions can lead to cell differen- 
tiation or contribute to reversible inductive phenomena 
within already differentiated cells (9). No definitive 
answer has yet been found for which of these different 
possibilities is effective in confining GS expression to 
this small hepatocyte population touching the central 
veins. To illustrate the complexity of this phenomenon, 
some of the arguments favoring the one or the other 
possibility are discussed below. 
Direct experimental evidence for the involvement of 
cell-cell interactions in the regulation of GS expression 
comes from cocultures between hepatocytes and so- 
called epitheloid cell lines of thus far unknown origin 
(10). Under appropriate culture conditions these cells 
spontaneously induce GS expression in originally 
enzyme-negative periportal hepatocytes that, in pure 
culture, would never acquire the ability to express GS. 
What is still puzzling with these coculture experiments 
is the fact that despite a more than 10-fold induction of 
GS in the periportal hepatocytes the level is still 
relatively low compared with the estimated activity of 
pure GS-positive hepatocytes. Furthermore, the hor- 
monal response of GS characteristic for originally 
GS-positive hepatocytes (2) is not established when 
GS-negative periportal hepatocytes are maintained in 
coculture. This does not seem to reflect limited perfor- 
mance of the cocultured hepatocytes because perivenous 
GS-positive hepatocytes maintain this regulation. 
Rather, it is likely that an important step generating 
truly GS-positive hepatocytes is missing. 
As shown by Schrode, Mecke and Gebhardt (10) the 
induction in the coculture system seems to be the result 
of the combined action of several inducing factors 
produced by the epitheloid cells: a heat and acid 
labile-soluble polypeptide factor and factors acting only 
within a limited distance, most likely components of the 
extracellular matrix. In addition, evidence has been seen 
for a soluble factor produced by periportal hepatocytes 
that might inhibit GS expression at least in cultured 
cells (10). 
Certainly, the balance of such positive and negative 
signals under in uiuo conditions might ensure that the 
enzyme distribution would show a very sharp border. 
However, if such signals do the whole job, what then is 
the difference between the extremely stable expression 
of GS and the more flexible expression of %- 
microglobulin (11) or of the brain-type glucose trans- 
porter (12), two proteins that normally show a distri- 
bution quite similar to GS but that can relatively easily 
be induced in adjacent, newly recruited hepatocytes? 
Obviously, the signals regulating these two proteins 
behave more in a dynamic, gradient-like fashion, al- 
though they might be produced by the endothelial cells 
of the terminal hepatic venules as well (11). 
At first glance, these findings seem to support simple 
enzyme induction as the mechanism, but some evidence 
also exists for the hypothesis that the massive ex- 
pression of GS in hepatocytes might be caused by a 
differentiating event (13). For instance, cell differenti- 
ation occurring in uiuo but not in the cocultures could 
explain why originally GS-positive hepatocytes remain 
enzyme positive for 10 days and more during pure 
cultivation even in the absence of inducing stimuli, 
whereas the induction of GS in periportal GS-negative 
hepatocytes during cocultivation that occurs already 
within 24 hr seems to be reversible (Schrode W, et al., 
Unpublished observation). Furthermore, the GS- 
positive hepatocyte population not only shows a distinct 
pattern of ploidy (6 )  but is also characterized by an 
individual proliferative potential in uitro, in uiuo and in 
experimental hepatocarcinogenesis (8, 13). 
Indeed, other examples exist of induced cell differen- 
tiation in the liver. Hepatocyte-mesenchyme interac- 
tions in the periportal limiting plate have been described 
as inducing the differentiation of bile ductular cells and 
the formation of bile ductules in the embryonic liver 
(14). Furthermore, Gumucio (15) recently summarized 
findings indicating that even after this event the 
hepatocytes of the first layers of periportal cells seem to 
be distinct from those in more downstream locations, 
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just as the GS-positive hepatocytes are at the opposite 
end of the acinus. 
In conclusion, short-range cell-cell interactions be- 
tween endothelial and mesenchymal cells of the portal 
triad or the central veins and the adjacent hepatocytes 
seem to play an important role in defining phenotypic 
characteristics of these hepatocytes. Even the possibility 
that these interactions lead to higher levels of differen- 
tiation remains a serious option. Thus the unequivocal 
demonstration of the importance of such interactions 
marks only the beginning of a new challenge for future 
hepatological studies. 
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NUTRITIONAL THERAPY FOR ALCOHOLIC 
HEPATITIS: ARE WE THERE YET? 
Kearns PJ, Young H, Garcia G, Blaschke T, O'Hanlon 
G, Rinki M, Sucher K, et al. Accelerated improvement of 
alcoholic liver disease with enteral nutrition. Gastroen- 
terology 1992;102:200-205. 
ABSTRACT 
This prospective study compared the effects of 
tube-fed nutrition with those of a regular diet in 
alcoholic liver disease. The high prevalence of malnu- 
trition in patients with alcoholic liver disease requires 
clarification of the benefits of aggressive nutritional 
support. Patients were randomly assigned a regular 
diet without or with tube-fed supplementation, deliv- 
ering 1.6 &protein and 167 kJ/kgdaily. Comparisons 
of encephalopathy, antipyrine clearance, metabolic 
rate, and biochemical parameters were performed 
weekly for 4 weeks. Sixteen patients receiving enteral 
supplementation had antipyrine half-life (50% vs. 3% 
reduction), serum bilirubin (26% vs. 0% reduction), and 
median encephalopathy scores that improved more 
rapidly than those of controls. Initially, 15 controls did 
not consume adequate calories to meet measured 
resting energy expenditure. Aggressive nutritional 
intervention accelerated improvement in alcoholic 
liver disease. Adverse effects did not offset the demon- 
strated benefits of a 2-cal/mL, casein-based tube-fed 
supplement. These hdings support the use of 
standard, casein-based solutions in the treatment of 
alcoholic liver disease and as the control condition for 
future studies. 
Bonkovsky HL, Fiellin DA, Smith GS, Slaker DP, 
Simon D, Galambos JT. A randomized, controlled trial 
of treatment of alcoholic hepatitis with parented 
nutrition and oxandrolone. I. Short-term effeds on liver 
function. Am J Gastroenterol 1991;86: 1200-1208. 
ABSTRACT 
The present studies were designed to provide careful 
measures of effects of oxandrolone, an anabolic 
steroid, intravenous nutritional supplementation, and 
the combination of these two treatments on liver 
functions, metabolic balances, nitrogen metabolism, 
and nutritional status in patients with moderate to 
severe alcoholic hepatitis. Of 43 patients originally 
recruited, 39 (19 men, 20 women) with typical clinical 
and laboratory features of alcoholic hepatitis (11 
Child's-Pugh class B; 28 class C) were admitted to a 
metabolic unit and completed a 36-day three-phase 
protocol. Phase I was a 10-day baseline period of 
observation, during which routine and special quanti- 
tative tests of liver function (galactose and antipyrine 
metabolism), a 7-day elemental balance study, and a 
laN, lsC-leucine metabolism study were done. Phase 11 
was a 21-day treatment period during which patients 
were randomly assigned to receive one of four reg- 
imens: 1) standard therapy, consisting of abetinence, a 
balanced, nutritionally adequate diet, and multivi- 
tnminn; 2) oxandrolone (20 mg orally four times a day) 
plus standard therapy; 3) nutritional supplementation, 
